Paper3979912
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.
Campieri M and 8 others. Gut, 1985. Cited by 64 papers, by iCite.
Cite this record
ConductScience Library. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Papers, record 3979912. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3979912
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminosalicylic Acids | Major topic |
| Colitis, Ulcerative | Major topic |
| Rectum | Major topic |
| Administration, Topical | |
| Enema | |
| Humans | |
| Intestinal Absorption | |
| Mesalamine |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6121181 | Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression. | Lancet | 1982 | https://conductscience.org/library/papers/6121181 | PubMed |
| 2 | 20791817 | Nephrotoxic lesions from 5-aminosalicylic Acid. | Br Med J | 1972 | https://conductscience.org/library/papers/20791817 | PubMed |
| 3 | 6114321 | Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas. | Lancet | 1981 | https://conductscience.org/library/papers/6114321 | PubMed |
| 4 | 6126289 | Rectal drug administration: clinical pharmacokinetic considerations. | Clin Pharmacokinet | 1982 | https://conductscience.org/library/papers/6126289 | PubMed |
| 5 | 1247769 | Plasma prednisolone levels after administration of prednisolone-21-phosphate as a retention enema in colitis. | Br Med J | 1976 | https://conductscience.org/library/papers/1247769 | PubMed |
| 6 | 6107853 | Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. | N Engl J Med | 1980 | https://conductscience.org/library/papers/6107853 | PubMed |
| 7 | 6118605 | Disodium azodisalicylate in ulcerative colitis. | Lancet | 1981 | https://conductscience.org/library/papers/6118605 | PubMed |
| 8 | 6110627 | On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon. | Hepatogastroenterology | 1980 | https://conductscience.org/library/papers/6110627 | PubMed |
| 9 | 4146729 | Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4146729 | PubMed |
| 10 | 6107263 | Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. | Gut | 1980 | https://conductscience.org/library/papers/6107263 | PubMed |
| 11 | 4405598 | Distribution studies of salicylazosulfapyridine and its metabolites. | Gastroenterology | 1973 | https://conductscience.org/library/papers/4405598 | PubMed |
| 12 | 7173720 | Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis. | Gut | 1982 | https://conductscience.org/library/papers/7173720 | PubMed |
| 13 | 7117789 | 5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans. | Gastroenterology | 1982 | https://conductscience.org/library/papers/7117789 | PubMed |
| 14 | 6117565 | Simplified high-performance liquid chromatographic method for 5-aminosalicylic acid in plasma and urine. | J Chromatogr | 1981 | https://conductscience.org/library/papers/6117565 | PubMed |
| 15 | 6113021 | Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6113021 | PubMed |
| 16 | 4800686 | Absorption of salicylic acid from the perfused human rectum. | Acta Pharmacol Toxicol (Copenh) | 1973 | https://conductscience.org/library/papers/4800686 | PubMed |
| 17 | 4402886 | Absorption, metabolism, and excretion of salicylazosulfapyridine in man. | Clin Pharmacol Ther | 1972 | https://conductscience.org/library/papers/4402886 | PubMed |
| 19 | 223947 | Plasma prednisolone levels and adrenocortical responsiveness after administration of prednisolone-21-phosphate as a retention enema. | Gut | 1979 | https://conductscience.org/library/papers/223947 | PubMed |
| 20 | 6381184 | A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis. | Digestion | 1984 | https://conductscience.org/library/papers/6381184 | PubMed |
| 21 | 6669934 | Absorption and excretion of azodisal sodium and its metabolites in man after rectal administration of a single 2-g dose. | Scand J Gastroenterol | 1983 | https://conductscience.org/library/papers/6669934 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33138176 | Anti-Inflammatory Activity of Chitosan and 5-Amino Salicylic Acid Combinations in Experimental Colitis. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/33138176 | PubMed |
| 29752633 | Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/29752633 | PubMed |
| 24707159 | Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/24707159 | PubMed |
| 16225364 | How important is onset of action in ulcerative colitis therapy? | Drugs | 2005 | https://conductscience.org/library/papers/16225364 | PubMed |
| 12534636 | Rectal ropivacaine is absorbed proportionally to the dose, with low intraindividual variability. | Br J Clin Pharmacol | 2003 | https://conductscience.org/library/papers/12534636 | PubMed |
| 10976656 | Clinical pharmacokinetics of slow release mesalazine. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10976656 | PubMed |
| 10759687 | Dose loading with delayed-release mesalazine: a study of tissue drug concentrations and standard pharmacokinetic parameters. | Br J Clin Pharmacol | 2000 | https://conductscience.org/library/papers/10759687 | PubMed |
| 9691909 | What dose of 5-aminosalicylic acid (mesalazine) in ulcerative colitis? | Gut | 1998 | https://conductscience.org/library/papers/9691909 | PubMed |
| 9149065 | Hypersensitivity to 5-ASA suppositories. | Dig Dis Sci | 1997 | https://conductscience.org/library/papers/9149065 | PubMed |
| 8801202 | A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. | Gut | 1996 | https://conductscience.org/library/papers/8801202 | PubMed |
| 8404405 | Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema. | Dig Dis Sci | 1993 | https://conductscience.org/library/papers/8404405 | PubMed |
| 7959212 | Mesalazine induced interstitial nephritis. | Gut | 1994 | https://conductscience.org/library/papers/7959212 | PubMed |
| 3678967 | Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis. | Gut | 1987 | https://conductscience.org/library/papers/3678967 | PubMed |
| 3319460 | Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis. | Dig Dis Sci | 1987 | https://conductscience.org/library/papers/3319460 | PubMed |
| 3207553 | Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3207553 | PubMed |
| 2899536 | Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse. | Gut | 1988 | https://conductscience.org/library/papers/2899536 | PubMed |
| 2702889 | 5-Aminosalicylic acid concentration in mucosal interstitium of cat small and large intestine. | Dig Dis Sci | 1989 | https://conductscience.org/library/papers/2702889 | PubMed |
| 2684592 | Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease. | Drugs | 1989 | https://conductscience.org/library/papers/2684592 | PubMed |
| 2651087 | Newer 5-aminosalicylic acid based drugs in chronic inflammatory bowel disease. | Drugs | 1989 | https://conductscience.org/library/papers/2651087 | PubMed |
| 1884566 | Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions. | Clin Pharmacokinet | 1991 | https://conductscience.org/library/papers/1884566 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3979912
GET https://conductscience.org/api/papers/v1/3979912/references?page=2